A CONDITIONING PLATFORM WITH FLUDARABINE, BUSULFAN AND ATG CONDUCTS TO IDENTICAL PROMISING RESULTS IN PATIENTS UNDERGOING ALLOGENEIC TRANSPLANTATION FROM BOTH MATCHED AND MISMATCHED UNRELATED DONOR

被引：0
|
作者：
Devillier, R. [1 ,2 ,3 ]
Furst, S. [1 ]
Crocchiolo, R. [1 ]
El-Cheikh, J. [1 ]
Castagna, L. [4 ]
Harbi, S. [1 ,2 ]
Granata, A. [1 ]
Chabannon, C. [1 ,2 ,3 ]
Calmels, B. [5 ]
Lemarie, C. [5 ]
Bouabdallah, R. [1 ]
Vey, N. [1 ,2 ,3 ]
Blaise, D. [1 ,2 ,3 ]
机构：
[1] Inst Paoli Calmettes, Hematol, Marseille, France
[2] Aix Marseille Univ, Marseille, France
[3] Ctr Rech Cancerol Marseille, Marseille, France
[4] Inst Clin Humanitas, Hematol, Milan, Italy
[5] Inst Paoli Calmettes, Cell Therapy, Marseille, France
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P367
引用
收藏
页码：156 / +
页数：2
相关论文
共 50 条
  • [31] Allogeneic hematopoietic cell transplantation without total body irradiation from unrelated donor in adult patients with idiopathic aplastic anemia: Fludarabine versus cyclophosphamide-ATG
    Kim, Hawk
    Lee, Kyoo-Hyung
    Kim, Inho
    Sohn, Sang Kyun
    Jung, Chul Won
    Joo, Young Don
    Kim, Sung-Hyun
    Kim, Byung Soo
    Choi, Jung Hye
    Kwak, Jae-Yong
    Kim, Min Kyoung
    Bae, Sung Hwa
    Shin, Ho Jin
    Won, Jong-Ho
    Lee, Won Sik
    Oh, Sukjoong
    Kim, Hyo Jung
    Park, Jae-Hoo
    LEUKEMIA RESEARCH, 2014, 38 (07) : 730 - 736
  • [32] Thiotepa, busulfan and fludarabine conditioning-regimen is a promising approach for older adult patients with acute lymphoblastic leukemia treated with allogeneic stem cell transplantation
    Anne Banet
    Ali Bazarbachi
    Myriam Labopin
    Nicolas Stocker
    Rémy Duléry
    Florent Malard
    Zoé Van de Wyngaert
    Alexis Genthon
    Mara Memoli
    Ollivier Legrand
    Agnes Bonnin
    Tounes Ledraa
    Ramdane Belhocine
    Simona Sestili
    Jean El-Cheikh
    Mohamad Mohty
    Eolia Brissot
    Bone Marrow Transplantation, 2023, 58 : 61 - 67
  • [33] Thiotepa, busulfan and fludarabine conditioning-regimen is a promising approach for older adult patients with acute lymphoblastic leukemia treated with allogeneic stem cell transplantation
    Banet, Anne
    Bazarbachi, Ali
    Labopin, Myriam
    Stocker, Nicolas
    Dulery, Remy
    Malard, Florent
    Van de Wyngaert, Zoe
    Genthon, Alexis
    Memoli, Mara
    Legrand, Ollivier
    Bonnin, Agnes
    Ledraa, Tounes
    Belhocine, Ramdane
    Sestili, Simona
    El-Cheikh, Jean
    Mohty, Mohamad
    Brissot, Eolia
    BONE MARROW TRANSPLANTATION, 2023, 58 (01) : 61 - 67
  • [34] COMPARISON OF IMMUNE RECONSTITUTION BETWEEN MATCHED UNRELATED AND HAPLOIDENTICAL DONOR FOR ALLOGENEIC STEM-CELL TRANSPLANTATION IN PATIENTS WITH ACUTE LEUKEMIA WITH IDENTICAL CONDITIONING AND PTCY GVHD-PROPHYLAXIS
    Massoud, Radwan
    Klyuchnikov, Evgeny
    Gagelmann, Nico
    Kunte, Ameya
    Fritzsche-Friedland, Ulrike
    Heinzelmann, Marion
    Zeck, Gaby
    Janson, Dietlinde
    Ayuk, Francis
    Wolschke, Christine
    Kroeger, Nicolaus
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 466 - 466
  • [35] Methotrexate or mycophenolate mofetil with cyclosporine and antithymocyte globulin in matched unrelated donor transplantation for acute myeloid leukemia with busulfan-fludarabine reduced-intensity conditioning: An alwp study
    Battipaglia, G.
    Galimard, J. -E.
    Labopin, M.
    Socie, G.
    Forcade, E.
    Bulabois, C. E.
    Schanz, U.
    Fegueux, N.
    Mielke, S.
    Carlson, K.
    Deconinck, E.
    Maertens, J.
    Guillerm, G.
    Turlure, P.
    Gedde-Dahl, T.
    Nagler, A.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 188 - 189
  • [36] Thiotepa–busulfan–fludarabine (TBF) conditioning regimen in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis: an outcome analysis from the Chronic Malignancies Working Party of the EBMT
    Giorgia Battipaglia
    Katya Mauff
    Lotus Wendel
    Emanuele Angelucci
    Mohamad Mohty
    William Arcese
    Stella Santarone
    Marie Therese Rubio
    Nicolaus Kroger
    Maria Laura Fox
    Didier Blaise
    Anna Paola Iori
    Renato Fanin
    Yves Chalandon
    Pietro Pioltelli
    Giuseppe Marotta
    Patrizia Chiusolo
    Matjaz Sever
    Carlos Solano
    Nathalie Contentin
    Liesbeth C. de Wreede
    Tomasz Czerw
    Juan Carlos Hernandez-Boluda
    Patrick Hayden
    Donal McLornan
    Ibrahim Yakoub-Agha
    Bone Marrow Transplantation, 2021, 56 : 1593 - 1602
  • [37] A uniform conditioning regimen of busulfan, fludarabine, and antithymocyte globulin for allogeneic haematopoietic cell transplantation from haploidentical family, matched sibling, or unrelated donors-A single-centre, prospective, explorative study
    Choi, Yunsuk
    Choi, Eun-Ji
    Park, Han-Seung
    Lee, Jung-Hee
    Lee, Je-Hwan
    Lee, Young-Shin
    Kang, Young-A
    Jeon, Mijin
    Woo, Ji Min
    Kang, Hyeran
    Baek, Seunghyun
    Kim, Su Mi
    Bong, Chae-Eun
    Lee, Kyoo-Hyung
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 200 (05) : 608 - 621
  • [38] REDUCED INTENSITY CONDITIONING REGIMEN AND ALLOGENEIC STEM CELL TRANSPLANTATION FROM RELATED OR UNRELATED HLA IDENTICAL DONOR IN ADVANCED SOLID TUMOURS
    Prete, A.
    Rondellion, R.
    Caselli, D.
    Lanino, E.
    Messina, C.
    Luksch, R.
    Pession, A.
    Zecca, M.
    Favre, C.
    Rabusin, M.
    Locatelli, F.
    Fagioli, F.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S66 - S66
  • [39] Reduced intensity conditioning regimen and allogeneic stem cell transplantation from related or unrelated HLA identical donor in high risk neuroblastoma
    Prete, A.
    Rondelli, R.
    Locatelli, F.
    Lanino, E.
    Favre, C.
    Rabusin, M.
    Pession, A.
    Fagioli, F.
    EJC SUPPLEMENTS, 2009, 7 (02): : 223 - 223
  • [40] Fludarabine/Treosulfan/Thiotepa/ATG Conditioning for Matched and Single Antigen Mismatched Unrelated Bone Marrow Transplantation in Haemoglobinopathies Is Feasible and Leads to Early and Sustanined Engraftment with No Long-Term Toxicity or GvHD
    O'Boyle, Farah
    Karnik, Leena
    Bradshaw, Anne
    Szydlo, Richard M.
    de la Fuente, Josu
    BLOOD, 2016, 128 (22)
12345